Odds of Pulmonary Embolism Up for Obese COVID-19 Patients
WEDNESDAY, May 20, 2020 -- Patients with COVID-19 with a body mass index (BMI)>30 kg/m² have increased odds of developing pulmonary embolism (PE), according to a research letter published online May 14 in Radiology.
Neo Poyiadi, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 20, 2020 Category: Pharmaceuticals Source Type: news
Could COVID-19 Finally Destigmatize Mental Illness?
There is a research model going around that suggests as many as 150,000 additional people could die from mental health-related outcomes of COVID-19. I could argue the merits of the mathematical model as many of my colleagues have. I could also make the case that discussing the depths of despair and predicting increasing suicide rates over and over could, in fact, lead to copycat suicides. But what if I took an alternative stance, and told you that—though absolutely no one would wish a pandemic on anyone— this is actually what mental health needed to stop being stigmatized and start being valued?
I’m not ...
Source: TIME: Health - May 13, 2020 Category: Consumer Health News Authors: Jessica Gold Tags: Uncategorized COVID-19 Source Type: news
High Rate of Pulmonary Embolism Found for Patients With COVID - 19
Two studies demonstrate high rate of PE; 100 percent sensitivity for PE seen for D - dimer level> 2,660 µ g/L (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - April 28, 2020 Category: Respiratory Medicine Tags: Family Medicine, Infections, Internal Medicine, Critical Care, Emergency Medicine, Pulmonology, Radiology, Journal, Source Type: news
High Rate of Pulmonary Embolism Found for Patients With COVID-19
TUESDAY, April 28, 2020 -- COVID-19 is associated with a high rate of pulmonary embolism, according to two research letters published online April 23 in Radiology.
Ian Leonard-Lorant, M.D., from the Nouvel Hôpital Civil in Strasbourg, France,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 28, 2020 Category: Pharmaceuticals Source Type: news
Landmark Phase 3 VOYAGER PAD Study of XARELTO ® (rivaroxaban) Plus Aspirin Shows Significant Benefit in Patients with Symptomatic Peripheral Artery Disease (PAD) after Lower-Extremity Revascularization
RARITAN, NJ, March 28, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the VOYAGER PAD study met its primary efficacy and principal safety endpoints, demonstrating the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily) plus aspirin (100 mg once daily) was superior to aspirin alone in reducing the risk of major adverse limb and cardiovascular (CV) events by 15 percent in patients with symptomatic peripheral artery disease (PAD) after lower-extremity revascularization, with similar rates of TIMI[1] major bleeding. VOYAGER PAD is the only study to show a significant benefit using...
Source: Johnson and Johnson - March 28, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
Janssen Highlights Continued Commitment to Cardiovascular & Metabolic Healthcare Solutions with Late-Breaking Data at the First Fully Virtual American College of Cardiology Scientific Session
RARITAN, N.J., March 20, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that it will unveil late-breaking data from its leading cardiovascular and metabolism portfolio during the virtual American College of Cardiology’s 69th Annual Scientific Session together with the World Congress of Cardiology (ACC.20/WCC) on March 28-30, 2020. Notably, four late-breaking abstracts for XARELTO® (rivaroxaban) will be presented, including data from the Phase 3 VOYAGER PAD study in patients with symptomatic peripheral artery disease (PAD) after lower-extremity revascularization.Click to Tweet: Jan...
Source: Johnson and Johnson - March 20, 2020 Category: Pharmaceuticals Source Type: news
10 Years Later, Obamacare ’s Complicated Legacy Still Shapes the Nation
Maurine Stuart credits the Affordable Care Act (ACA) for saving her family. In 2014, Stuart was diagnosed with HELLP syndrome, a rare disease that causes heart, liver and lymphatic problems. As a result, she was unable to continue working full time—which meant losing her employer-sponsored health insurance. But thankfully, she says, that same year, her home state of West Virginia opted in to the 2010 Affordable Care Act’s Medicaid-coverage expansion, and she qualified.
Over the next few years, as bad news kept rolling in, ACA protections continued to keep Stuart’s family afloat. When Stuart was diagnosed ...
Source: TIME: Health - March 19, 2020 Category: Consumer Health News Authors: Abigail Abrams Tags: Uncategorized Source Type: news
Clinical Impact of AF in Patients With Pulmonary Embolism Clinical Impact of AF in Patients With Pulmonary Embolism
This study aimed to assess the prevalence of atrial fibrillation in patients with confirmed acute pulmonary embolism. How does AF impact complications and outcomes in these patients?Southern Medical Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 3, 2020 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news
Outpatient Management of Low-risk Pulmonary Embolism Outpatient Management of Low-risk Pulmonary Embolism
A new trial adds to the growing evidence that outpatient treatment of selected low-risk patients with pulmonary embolism can be done safely and effectively.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 26, 2020 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
U.S. Emergency Departments Over-Test for Suspected PE U.S. Emergency Departments Over-Test for Suspected PE
Overuse of computerized tomographic pulmonary angiography (CTPA) to rule out pulmonary embolism (PE) in U.S. emergency departments is costly and puts patients at risk for multiple adverse outcomes, a cross-sectional analysis suggests.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - February 12, 2020 Category: Radiology Tags: Pulmonary Medicine News Source Type: news
Pulmonary Embolism
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 22, 2020 Category: General Medicine Source Type: news
Aidoc secures FDA clearance for AI stroke software
The U.S. Food and Drug Administration (FDA) has cleared Israeli artificial...Read more on AuntMinnie.comRelated Reading:
Aidoc reports customer milestone
Aidoc releases full AI software package for stroke care
Aidoc nabs NY contract for AI software
FDA clears Aidoc's AI for cervical spine fractures
Aidoc scores FDA clearance for pulmonary embolism AI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 13, 2020 Category: Radiology Source Type: news
FDA approves first generics of Eliquis
The U.S. Food and Drug Administration has approved two applications for the first generics of Eliquis (apixaban) tablets to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Apixaban is also indicated for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery. (Source: World Pharma News)
Source: World Pharma News - December 26, 2019 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news
Fatal Embolism Infrequent, but Fuels Overdiagnosis Fatal Embolism Infrequent, but Fuels Overdiagnosis
In most cases clots are small and are not deadly, but in a controversy session on overdiagnosis, specialists agreed on one thing: Not all pulmonary embolisms are equal.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 12, 2019 Category: Consumer Health News Tags: Radiology News Source Type: news
Aidoc reports customer milestone
Israeli artificial intelligence software developer Aidoc said that the Foundation...Read more on AuntMinnie.comRelated Reading:
Aidoc releases full AI software package for stroke care
Aidoc nabs NY contract for AI software
FDA clears Aidoc's AI for cervical spine fractures
Aidoc scores FDA clearance for pulmonary embolism AI
Aidoc raises $27M in funding round (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 11, 2019 Category: Radiology Source Type: news
